Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Type of Technology
6.1 Bioinformatics
6.2 Drug Discovery
6.3 Gene Sequencing
6.4 Big Data Analytics
6.5 Companion Diagnostics
6.6 Pharmacogenomics
Chapter 7 Market Segmentation by Applications
7.1 Immunology
7.2 Respiratory
7.3 Neurology
7.4 Cardiology
7.5 CNS
Chapter 8 Market Segmentation by Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 Spain
8.2.3 UK
8.2.4 France
8.2.5 Russia
8.2.6 Italy
8.2.7 Others
8.3 Asia Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Nanostring Technologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2 Roche Holding
10.3 Intomics
10.4 Biocrates Life Sciences
10.5 Silicon Biosystems
10.6 Ferrer InCode
10.7 Pfizer
10.8 Tepnel Pharma Services
10.9 Eagle Genomics
10.10 Covance
10.11 Source Precision Medicine
10.12 Laboratory Corporation of America Holdings
10.13 Medtronic
10.14 Quest Diagnostics
10.15 Teva Pharmaceuticals
Chapter 11 Market Estimates and Forecasting
11.1 Market Estimates and Forecasting 2018-2024(USD Million)
11.1.1 Market Estimation and Forecasting by Type of Technology 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
